Evidence map›Paper›PMID 35004300›Full record

ArticleFrontiers in oncology2021

Case Report: Opposite Effects of

Katrin E Hostettler, Elisa Casañas Quintana, Michael Tamm, Spasenija Savic Prince, Gregor Sommer, Wei-Chih Chen, Thierry Michael Nordmann, Pontus Lundberg, Gregor Thomas Stehle, Thomas Daikeler

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. A Case of Primary Cutaneous BRAFThe Australasian journal of dermatology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Katrin E HostettlerClinics of Respiratory Medicine, University Hospital Basel, Basel, Switzerland.
Elisa Casañas QuintanaEmergency Department, University Hospital Basel, Basel, Switzerland.
Michael TammClinics of Respiratory Medicine, University Hospital Basel, Basel, Switzerland.
Spasenija Savic PrincePathology, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
Gregor SommerClinic of Radiology and Nuclear Medicine, University Hospital of Basel, Basel, Switzerland.
Wei-Chih ChenDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Thierry Michael NordmannDepartment of Dermatology, University Children's Hospital Zurich, Zurich, Switzerland.
Pontus LundbergDivision of Hematology, University Hospital of Basel, Basel, Switzerland.
Gregor Thomas StehleDivision of Hematology, University Hospital of Basel, Basel, Switzerland.
Thomas DaikelerDepartment of Rheumatology, University Hospital of Basel, Basel, Switzerland.
University Hospital of Basel · CHTaipei Veterans General Hospital · TWUniversity Children's Hospital Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Langerhans cell histiocytosis (LCH) commonly co-occurs with additional myeloid malignancies. The introduction of targeted therapies, blocking "driver" mutations (e.g.,

Indexed as

acute myeloid leukemiaAML—acute myeloid leukemiaBRAF inhibitioncase reporthematopoietic stem cell transplantationLangerhans cell histiocytosis

Identifiers

PMID35004300
PMCPMC8739218
OpenAlexW4200541478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.